India, Sept. 24 -- Hyloris Pharmaceuticals SA (HYL.BR) reported Loss for first half of -EUR1.87 million
The company's bottom line totaled -EUR1.87 million, or -EUR0.07 per share. This compares with -EUR3.55 million, or -EUR0.13 per share, last year.
The company's revenue for the period rose 55.3% to EUR4.69 million from EUR3.02 million last year.
Hyloris Pharmaceuticals SA earnings at a glance (GAAP) :
-Earnings: -EUR1.87 Mln. vs. -EUR3.55 Mln. last year.-EPS: -EUR0.07 vs. -EUR0.13 last year.-Revenue: EUR4.69 Mln vs. EUR3.02 Mln last year.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....